Pierre Scheffler

Pierre Scheffler

Auto-generated profile, based on publicly available information

Pierre Scheffler

Department of Neurosurgery, Medical Center, University of Freiburg , Freiburg

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
PSPierre Scheffler
Pierre Scheffler
CFChristian Fung
Christian Fung
SMShahan Momjian
Shahan Momjian
DKDominik Koessinger
Dominik Koessinger
LHLevin Häni
Levin Häni
ARAmir El Rahal
Amir El Rahal
Objective: Glioblastomas are the most common primary central nervous system (CNS) tumors. Although modern management strategies have modestly improved overall survival, the prognosis remains dismal, with treatment side effects often impinging on the clinical course. Glioblastomas cause neurological dysfunction by infiltrating CNS tissue and via perifocal oedema formation. The administration of steroids such as dexamethasone is thought to alleviate symptoms by reducing oedema. However, despite its widespread use, the evidence for the administration of dexamethasone is limited and conflicting. Therefore, we aimed to review the current evidence concerning the use and outcomes of dexamethasone in patients with glioblastoma. Methods: We performed a systematic review and meta-analysis according to the PRISMA-P guidelines. We performed a restricted search using the keywords “Dexamethasone” and “Glioblastoma” on PubMed, Web of Science, Cochrane Library, and Academic Search Premier. We included studies reporting on overall survival (OS) and progression-free survival (PFS) in glioblastoma patients receiving higher or lower dexamethasone doses. The risk of bias was assessed using ROBINS-I. We performed a meta-analysis using a random effects model for OS and PFS. Results: Twenty-two retrospective studies were included. Higher doses of dexamethasone were associated with poorer OS (hazard ratio 1.62, confidence interval 1.40–1.88) and PFS (1.49, 1.23–1.81). OS remained worse even when studies corrected for clinical status (1.52, 1.38–1.67). Conclusion: Despite the widespread use of dexamethasone in glioblastoma patients, its use is correlated with worse long-term outcomes. Consequently, Dexamethasone administration should be restricted to selected symptomatic patients. Future prospective studies are crucial to confirm these findings.

26 January 2025 in Brain and Spine
Verified
Journal Article
Open access
PSPierre Scheffler
Pierre Scheffler
JSJakob Straehle
Jakob Straehle
ARAmir El Rahal
Amir El Rahal
DEDaniel Erny
Daniel Erny
BMBoris Mizaikoff
Boris Mizaikoff
NNNicolas Neidert
Nicolas Neidert
Early diagnosis is important to differentiate central nervous system lymphomas (CNSL) from the main differential diagnosis, glioblastoma (GBM), because of different primary treatment modalities for these entities. Due to neurological deficits, diagnostic stereotactic biopsies often need to be performed urgently. In this setting the availability of an intraoperative neuropathological assessment is limited. This study uses AI-based analysis of Stimulated Raman Histology (SRH) to establish a classifier distinguishing CNSL from glioblastoma in an intraoperative setting. We collected 126 intraoperative SRH images from 40 patients diagnosed with CNSL. These SRH images were divided into patches, measuring 224 x 224 pixels each. Additionally, we used a comparative dataset of 87 SRH images from 31 patients with GBM as a control group to train and validate a neural network based on the CTransPath architecture. Two distinct diagnostic categories were established: “Lymphoma” and “Glioblastoma". Our model demonstrated an accuracy rate of 92.5% in distinguishing between lymphoma and glioblastoma. Analysis of our test dataset showed a sensitivity of 84.2% and a specificity of 100% in the detection of CNSL, demonstrating performance comparable to standard intraoperative histopathological analysis. The use of AI-driven analysis of SRH images holds promise for intraoperative tissue examination of stereotactic biopsies with suspected CNSL en par with the current gold standard. This study could improve the management of these cases especially in the emergency setting when conventional intraoperative neuropathological evaluation is unavailable.

15 June 2021 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
PSPierre Scheffler
Pierre Scheffler
MOMarkus Florian Oertel
Markus Florian Oertel
LSLennart Henning Stieglitz
Lennart Henning Stieglitz
BACKGROUND: Normal pressure hydrocephalus (NPH) is frequently treated with ventriculoperitoneal shunt (VPS) surgery. However, VPS implantation can lead to overdrainage and complications such as headaches, hygroma, and subdural hematoma due to a siphon effect in an upright position. Gravitational valves prevent overdrainage through position-dependent adjustment of valve resistance. Flow-regulated valves that increase resistance in presence of high cerebrospinal fluid flow may provide similar protection against overdrainage and present an alternative to gravitational valves. OBJECTIVE: To compare gravitational and flow-regulated shunt valves in patients with symptomatic NPH. METHODS: We performed a retrospective analysis of 97 patients suffering from NPH who underwent VPS implantation with a gravitational or a flow-regulated valve. The primary endpoint was the occurrence of hygroma or subdural hematoma. Secondary endpoints were neurological outcome (Kiefer score, Stein and Langfitt score, and NPH recovery rate), frequency of valve adjustments, and reoperations. RESULTS: No significant differences in the occurrence of hygroma and subdural hematoma (11.4% for flow-regulated valves vs 5.7% for gravitational valves, P = .462) or response to treatment (77.3% vs 81.1%, P = .802) were found. Patients with flow-regulated valves required fewer valve adjustments (1.12 vs 2.02, P < .001) to reach their optimal neurological outcome and underwent fewer surgical revisions (11.4% vs 28.3%, P = .047). CONCLUSION: Our data suggest that shunt therapy in NPH patients with a flow-regulated instead of a gravitational valve is safe and effective with a comparable clinical outcome and risk of overdrainage complications. Moreover, patients with flow-regulated valves may need fewer valve adjustments and reoperations.

29 September 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MOManou Overstijns
Manou Overstijns
SNSameer Nazeeruddin
Sameer Nazeeruddin
PSPierre Scheffler
Pierre Scheffler
RRRoland Roelz
Roland Roelz
JBJürgen Beck
Jürgen Beck
ARAmir El Rahal
Amir El Rahal
Objectives: The increasing incidence of unruptured intracranial aneurysms (UIAs) has led to significant demands on neurovascular boards. Large language models (LLMs), such as ChatGPT-4, ChatGPT-3.5, Claude, and Atlas GPT, have emerged as tools to support clinical decision-making. This study compares treatment recommendations from these AI models with those of an interdisciplinary neurovascular board to evaluate their accuracy and alignment. Methods: We retrospectively included all 57 patients with UIAs discussed by the neurovascular board in 2023. The board’s consensus decision served as the reference standard. Key clinical and radiographic data, including PHASES, ELAPSS, and UIATS scores, were provided to the AI models. Each model was tasked with recommending either conservative or operative management and specifying the treatment modality (clipping, coiling, flow diverter, or WEB device/flow diverter) where appropriate. AI model recommendations were compared with the board’s decisions for management and the specific treatment modality of the UIA. Results: ChatGPT-4 achieved the highest accuracy in correctly predicting conservative or operative management (89%) and specific treatment types (73%), followed by Atlas GPT (74% accuracy in conservative/operative decisions and 55% accuracy in specific treatment types), Claude (70% accuracy in conservative/operative decisions and 50% accuracy in specific treatment types), and ChatGPT-3.5 (82% accuracy in conservative/operative decisions and 27% accuracy in specific treatment types). ChatGPT-3.5 displayed a strong preference for clipping (94.3%). ELAPSS scores significantly influenced AI recommendations and decision-making, particularly for ChatGPT-4 and ChatGPT-3.5. Follow-up recommendations for conservative management were shorter among AI models, with Claude suggesting the shortest interval (7.72 months) compared to the neurovascular board’s 13.36 months. Conclusions: AI models, particularly ChatGPT-4, align closely with expert neurovascular board decisions and offer promising support for initial clinical decision-making, particularly in resource-limited settings. However, interdisciplinary neurovascular boards remain unreplaceable for UIA management, and AI should be viewed as a complementary tool. The observed improvement from ChatGPT-3.5 to ChatGPT-4 underscores the rapid evolution of AI technology, and further advancements are expected to enhance both performance and accuracy in the future.

28 February 2025 in Brain and Spine
Verified
Journal Article
Open access
RWRalf Watzlawick
Ralf Watzlawick
PFPanagiotis Fistouris
Panagiotis Fistouris
AEAhmed Elbaz
Ahmed Elbaz
PSPierre Scheffler
Pierre Scheffler
ABAlix Bührle
Alix Bührle
JBJürgen Beck
Jürgen Beck
Treatment of spontaneous intracerebral hemorrhage (ICH) remains challenging, and intracerebral mass and brain edema (IMBE) are accused of being the main factors influencing patient course. CT scan assessment of the space-occupying effect after initial ICH was evaluated using an IMBE-score to detect the sulcal effacement of the subarachnoid space. Supratentorial ICH-patients within a 10 years observation period were identified. Two independent reviewers screened each CT scan in three defined axial planes. Where the combined mass effect of hemorrhage and edema showed sulcal effacement of more than half of the hemisphere, one point was assigned, resulting in an IMBES between 0 and 6. The primary endpoint was neurological outcome measured by the modified Rankin Scale (mRS) and mortality. We identified 762 patients, median age was 75.4 years (IQR: 64.3–81.1) and mean ICH volume was 46.1 cc. Multiple regression for mRS at discharge (mean: 12.5 days, IQR: 7.1–22.3) identified age, presence of intraventricular hemorrhage, ICH volume, renal insufficiency, intake of anticoagulants and IMBES as statistically significant variables. This was confirmed during follow-up examination, although ICH volume was not significantly associated with neurological outcome. We observed a decreased neurological recovery and an increased mortality for patients with high IMBES during acute care and at early follow-up, indicating that IMBES had the strongest association in all regression analysis. We conclude that the fast and simple IMBES may be a useful tool to estimate patient risk for impaired neurological outcome and death.

12 January 2026 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
XHXinhai Hou
Xinhai Hou
AKAkhil V Kondepudi
Akhil V Kondepudi
CJCheng Jiang
Cheng Jiang
YLYiwei Lyu
Yiwei Lyu
EHEdward Samir Harake
Edward Samir Harake
THTodd Hollon
Todd Hollon
The importance of rapid and accurate histologic analysis of surgical tissue in the operating room has been recognized for over a century. Our standard-of-care intraoperative pathology workflow is based on light microscopy and H&E histology, which is slow, resource-intensive, and lacks real-time digital imaging capabilities. Here, we describe an emerging and innovative method for intraoperative histologic analysis, called Intelligent Histology, that integrates artificial intelligence (AI) with stimulated Raman histology (SRH). SRH is a rapid, label-free, digital imaging method for real-time microscopic tumor tissue analysis. SRH generates high-resolution digital images of surgical specimens within seconds, enabling AI-driven tumor histologic analysis, molecular classification, and tumor infiltration detection. We review the scientific background, clinical translation, and future applications of intelligent histology in tumor neurosurgery. We focus on the major scientific and clinical studies that have demonstrated the transformative potential of intelligent histology across multiple neurosurgical specialties, including neurosurgical oncology, skull base, spine oncology, pediatric tumors, and peripheral nerve tumors. Future directions include the development of AI foundation models through multi-institutional datasets, incorporating clinical and radiologic data for multimodal learning, and predicting patient outcomes. Intelligent histology represents a transformative intraoperative workflow that can reinvent real-time tumor analysis for 21st century neurosurgery.